No evidence IV vitamin C aids critically ill COVID-19 patients
Covid19-Sources
Long-term health impacts of COVID-19 among 242,712 adults in England
Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas - PubMed
Is COVID-19 to Blame? Trends of Incidence and Sex Ratio in Youth-Onset Type 2 Diabetes in Germany
Body Mass Index Among Children and Adolescents During the COVID-19
A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
Coronavirus-Infektion ohne Symptome: Müssen Beschäftigte zur Arbeit?
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection
Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
Fortschritte in der Erforschung der SARS-CoV-2-Infektionen
The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
Serotonin reduction in post-acute sequelae of viral infection
SARS‐CoV‐2 infection correlates with male benign prostatic hyperplasia deterioration
The burden and dynamics of hospital-acquired SARS-CoV-2 in England
SARS-CoV-2 BA.2.86 (“Pirola”): Is it Pi or Just Another Omicron Sublineage?
Assessing and improving the validity of COVID-19 autopsy studies - A multicentre approach to establish essential standards for immunohistochemical and ultrastructural analyses
Endothelial cell infection and endotheliitis in COVID-19
Ist covid 19 eine gefaesserkrankung
An atlas of continuous adaptive evolution in endemic human viruses
Americans Don’t Get to Have the Best New COVID Drug
Dr. Gustavo Aguirre-Chang on Twitter
Bacterial coinfections contribute to severe COVID-19 in winter
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Could SARS-CoV-2 Have Bacteriophage Behavior or Induce the Activity of Other Bacteriophages?
Viral kinetics of sequential SARS-CoV-2 infections
In individuals with multiple infections, second infections were cleared more quickly than first infections. Furthermore, one’s relative speed of clearing infection roughly persisted across infections. Those with a relatively fast clearance speed in their first infection tended to have a relatively fast clearance speed in their second infection, and vice versa. Thus, while prior infection and vaccination can modulate a person’s viral kinetics in absolute terms, there may also exist some further immunological mechanism, conserved across sequential infections, that determines one’s strength of immune response against SARS-CoV-2 relative to others in the population.
A consistent finding between this and other studies on SARS-CoV-2 viral kinetics is that prior antigenic exposure, through infection or vaccination, tends to speed up viral clearance, and thus to reduce the duration of test positivity5,11,15. The duration of viral positivity has various consequences both for clinical management and for public health surveillance. For clinical management, test results should be interpreted in the context of a patient’s immune history, which can modulate both the extent and expected duration of viral shedding5,16. It may also be possible to adjust the recommended duration of post-infection isolation based on infection history.
COVID-19 vaccine-associated mortality in the Southern Hemisphere
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence